SEC Filings
Press Releases
February 5, 2010 Health Discovery Corporation Partners with Major New York City Pancreatic Cancer Center to Develop a New Molecular Diagnostic Test for the Early Detection of Pancreatic Cancer
February 3, 2010 Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment
February 2, 2010 Health Discovery Corporation's Test May Help Curb the Second-Leading Cause of Cancer Death.
November 30, 2009 Health Discovery Corporation Appoints Tom Gallagher, former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies
November 4, 2009 Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on the Value of Prostate Cancer Screening and Invites the American Cancer Society to Act Immediately
October 19, 2009 Health Discovery Corporation Announces Addtional Issued Patents and Notices of Allowances to Its Intellectual Property Portfolio
October 9, 2009 Health Discovery Corporation Hires The Dilenschneider Group, a New Yourk City IR/PR Firm
September 24, 2009 Health Discovery Corporation's Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize the Field of Molecular Diagnostics
September 18, 2009 Former Deputy FDA Commissioner John Norris Appointed Chief Operating Officer at Health Discovery Corporation
July 14, 2009 Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient
May 4, 2009 Health Discovery Corporation Names R. Scott Tobin as President and General Counsel
February 5, 2009 Health Discovery Corporation Licenses Biomarkers for Noninvasive Urine-Based Prostate Cancer Test to Quest Diagnostics
February 5, 2009 Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott
January 13, 2009 Clarient Launches Gene Expression Test for Prostate Cancer
